Qdot Probes

Pittsburgh, United States Founded: 1998 • Age: 28 yrs Acquired By Invitrogen
Quantum Dots Nanotech for molecular fluorescent imaging

About Qdot Probes

Qdot Probes is a Healthcare company based in Pittsburgh (United States) founded in 1998, and was acquired by Invitrogen in October 2005. Quantum Dots Nanotech for molecular fluorescent imaging. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its competitors include SpectraWAVE, Ionpath and Invenio Imaging; 3 of its 3 listed competitors have raised funding.

Company details

Quantum Dot Corporation (QDC, now part of Thermo Fisher) licensed nanocrystal technologies developed at Berkeley Lab by Dr. Paul Alivisatos, Shimon Weiss, and colleagues. Due to their unique light emitting properties, Qdots are superior to dye molecules now in use since they allow the simultaneous, color-coded identification of multiple cell structures. Qdots have potential applications in genotyping, DNA expression analysis, protein expression analysis, DNA sequencing, biological assays, imaging systems, research instrumentation, optical bar-coding of chemical and biological materials, tagging systems, and high-throughput screening. Quantum Dot Corporation was acquired by Invitrogen Corporation (now part of Thermo Fisher) in Oct 2005

  • Headquarters Pittsburgh, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website qdots.com
  • Social LinkedIn X Facebook
  • Acquired by Invitrogen (Oct 2005)
Key Metrics
  • Latest Funding Round
    $2M (USD), Grant

    Sep 2004

  • Investors
    NIST

    & 1 more

  • Acquired by
    Invitrogen

    (Oct 2005)

Funding Insights of Qdot Probes

  • Total Rounds 1
  • Last Round Grant β€” $2M
  • First Round $2M

    (Sep 2004)

  • Investors Count 1

All 1 funding rounds of Qdot Probes with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2004$2MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in Qdot Probes

Qdot Probes has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIST and Invitrogen.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Standards and measurements are developed by NIST for various industries.
1901nist.govUnited States
Provider of scientific instruments, services, and consumables
1987invitrogen.comCarlsbad, United States
Premium access

Investor details for Qdot Probes

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Qdot Probes

3 dated milestones of Qdot Probes across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Qdot Probes is founded.
  2. Funding First funding round of $2.0M.
  3. Exit Acquired by Invitrogen.

Competitors of Qdot Probes

Qdot Probes has 3 listed competitors in our database, 3 of them funded. They include SpectraWAVE, Ionpath and Invenio Imaging.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
spectrawave.com2012Waltham, United States$79.88M36
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
ionpath.com2014Menlo Park, United States$18M37
Multiplexed ion beam imaging platform for tissue biopsies is developed.
invenio-imaging.com2012Santa Clara, United States$7.5M
Provider of a tissue imagine software and hardware solution for research diagnosis
Premium access

Detailed competitors of Qdot Probes

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Qdot Probes (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Qdot Probes

Qdot Probes was founded in 1998 and raised its 1st funding round 6 years after it was founded.

Qdot Probes is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.

Quantum Dot Corporation (QDC, now part of Thermo Fisher) licensed nanocrystal technologies developed at Berkeley Lab by Dr. Paul Alivisatos, Shimon Weiss, and colleagues. Due to their unique light emitting properties, Qdots are superior to dye molecules now in use since they allow the simultaneous, color-coded identification of multiple cell structures. Qdots have potential applications in genotyping, DNA expression analysis, protein expression analysis, DNA sequencing, biological assays, imaging systems, research instrumentation, optical bar-coding of chemical and biological materials, tagging systems, and high-throughput screening. Quantum Dot Corporation was acquired by Invitrogen Corporation (now part of Thermo Fisher) in Oct 2005.

Qdot Probes's top competitors include Ionpath, SpectraWAVE and Invenio Imaging.

Qdot Probes has 2 investors. Key investors include NIST, and Invitrogen.

Yes. Qdot Probes was acquired by Invitrogen in October 2005.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available